Stocks · Health care · Biological Products, (No Diagnostic Substances)

Metagenomi Therapeutics, Inc.

MGX Clue Score24
United States Fiscal year ends December CIK 0001785279 Results filed 10 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Laurence Reid
9 Sep 2026
Director
Buy
117
$1.18
$138.06
Laurence Reid
9 Sep 2026
Director
Buy
19,883
$1.17
$23.26K

What was left out

Form 4 filings counted 25
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 13
Transactions with no price 0
Shares from compensation/vesting 773,962
History held since 14 Feb 2024